Home Product Liability Ditropan Dementia Lawsuit

Ditropan Dementia Lawsuit

Overactive bladder (OAB) drugs Ditropan and Ditropan XL may be linked to an increased risk of dementia, particularly in the elderly. Drug manufacturer Janssen and parent company Johnson & Johnson may be facing multiple Ditropan dementia lawsuits. People or loved ones of those who took Ditropan or Ditropan XL may have been placed at risk for dementia and may be eligible for compensation.

Open, accepting new clients
Ditropan dementia lawsuit

What’s on this page:

Free Case Evaluation
Accepting Clients Nationwide
All required fields are marked with an asterisk "*"

By submitting this form I agree to the terms of SeegerWeiss.com Terms & Conditions and Privacy Policy.

This field is for validation purposes and should be left unchanged.

Firm News

May 24, 2024
Lawdragon Names Nine Seeger Weiss Partners to 500 Plaintiff Financial Lawyers List

Seeger Weiss is proud to announce that Lawdragon recognized nine partners — Chris Seeger, Stephen Weiss, David Buchanan, Shauna Itri, Jennifer Scullion, Chris Ayers, Ben Barnett, Parvin Aminolroaya, and Steve Daroci — on the 2024 500 Leading Plaintiff Financial Lawyers list. This guide, first published in 2007 by Lawdragon Inc., presents Lawdragon’s opinion of “the […]

Read More
May 13, 2024
Seeger Weiss, Chris Seeger Named Elite Trial Lawyers Plaintiff Firm of the Year and Plaintiff Attorney of the Year Finalists; Parvin Aminolroaya Wins Elite Women of the Plaintiffs Bar Award

Seeger Weiss is pleased to announce that the firm and several of its partners have won or are finalists for multiple 2024 National Law Journal Elite Trial Lawyers Awards. Seeger Weiss was named a finalist for: Plaintiffs Firm of the Year Environmental Protection Practice Group of the Year Government Representation Practice Group of the Year […]

Read More
May 9, 2024
Seeger Weiss Reaches $1.1 Billion Personal Injury and Medical Monitoring Settlement in Philips CPAPs, Bi-PAPs, and Ventilators Litigation

Seeger Weiss founder and court-appointed co-lead counsel Chris Seeger secured a nearly $1.1 billion settlement in the Philips Recalled CPAP, Bi-Level Pap, and Mechanical Ventilator Products Litigation. The agreement provides $1.075 billion to compensate patients who suffered injuries while using recalled Philips devices and also includes $25 million to cover the cost of medical monitoring […]

Read More
May 9, 2024
Seeger Weiss Partner Parvin Aminolroaya Appointed Co-lead Counsel In Ozempic Litigation

RIDGEFIELD PARK, NJ — Seeger Weiss is pleased to announce that partner Parvin K. Aminolroaya has been appointed to serve as plaintiffs’ co-lead counsel in the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation by the honorable Judge Gene E. K. Pratter. This litigation consolidates dozens of lawsuits against drugmakers Novo Nordisk and Eli […]

Read More